Apollomics Inc.
APLM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.
Other share classesAPLMW
Key figures
- Insider buysLast 90 days, $8.25M in total
- 3
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 4
- 13F valueReported value at the end of Q2 2026
- $223.8K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding APLM, Q2 2026
No superinvestor reported holding APLM at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Apollomics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)7:32 PM ET | Aug 14 | 3 days | Chen Yi-KueiChief Operating Officer | PPurchaseCLASS A ORDINARY SHARES | +20.0K | $15.00 | +$300.0K | +19.8%121.2K after | |
| Aug 17, 2026 (view filing)7:23 PM ET | Aug 14 | 3 days | Lin Peter Kuan-HowChief Financial Officer | PPurchaseCLASS A ORDINARY SHARES | +26.7K | $15.00 | +$400.0K | +119.5%49.0K after | |
| Aug 17, 2026 (view filing)7:13 PM ET | Aug 14 | 3 days | Chen Hung-WenChief Executive Officer | PPurchaseCLASS A ORDINARY SHARES | +270.0K | $13.15 | +$3.55M | +182.0%418.3K after | 2 lots |
| Aug 17, 2026 (view filing)7:13 PM ET | Aug 14 | 3 days | Chen Hung-WenChief Executive Officer | PPurchaseCLASS A ORDINARY SHARES | +266.7K | $15.00 | +$4.00M | +34.9%1.03M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Apollomics Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 10,664 | $223.5K | 0.00% | +10,664 | New |
| SBI Securities Co., Ltd. | 9 | $189 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2 | $42 | 0.00% | −140−98.6% | Reduced |
| BlackRock, Inc. | 1 | $21 | 0.00% | 00.0% | Unchanged |